# Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?

> **NCT01373125** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 99 (actual)

## Conditions studied

- Barrett's Esophagus
- Intestinal Metaplasia
- Gastroesophageal Reflux Disease (GERD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01373125
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2015-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373125, "Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01373125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*